Lipid pneumonia

Short description: Lung inflammation caused by lipids in the bronchial tree

Lipoid pneumonia

Other names| Lipoid pneumonia, cholesterol pneumonia
Lipid pneumonia, exogenous Case 108

Lipoid pneumonia is a specific form of lung inflammation (pneumonia) that develops when lipids enter the bronchial tree. The disorder is sometimes called cholesterol pneumonia in cases where that lipid is a factor.[1]

## Contents

* 1 Signs and symptoms
* 2 Causes
* 2.1 Exogenous
* 2.1.1 Tuberculosis
* 2.2 Endogenous
* 3 Appearance
* 4 Diagnosis
* 5 Management
* 6 Prognosis
* 7 Epidemiology
* 8 History
* 9 References
* 10 Further reading
* 11 External links

## Signs and symptoms

The pneumonia presents as a foreign body reaction causing cough, dyspnea, and often fever. Hemoptysis has also been reported.[2]

## Causes

Sources of such lipids could be either exogenous or endogenous.[3]

### Exogenous

From outside the body. For example, inhaled nose drops with an oil base, or accidental inhalation of cosmetic oil. Amiodarone is an anti-arrythmic known to cause this condition. Oil pulling has also been shown to be a cause.[4] Fire breather's pneumonia from the inhalation of hydrocarbon fuel is a specific variant. At risk populations include the elderly, developmentally delayed or persons with gastroesophageal reflux. Switching to water-soluble alternatives may be helpful in some situations.[2]

#### Tuberculosis

A secondary tuberculosis in humans often begins as a lipid pneumonia.[5] This may be due to high content of mycolic acid, cord factor, and Wax-D in the cell wall of M. tuberculosis, that has long been speculated to be a virulence factor of the mycobacteria.[5]

### Endogenous

From the body itself, for example, when an airway is obstructed, it is often the case that distal to the obstruction, lipid-laden macrophages and giant cells fill the lumen of the disconnected airspace.[6]

## Appearance

The gross appearance of a lipid pneumonia is that in which there is an ill-defined, pale yellow area on the lung. This yellow appearance explains the colloquial term "golden" pneumonia.[7]

At the microscopic scale foamy macrophages and giant cells are seen in the airways, and the inflammatory response is visible in the parenchyma.[citation needed]

On CT, lipoid pneumonia appears as a "crazy paving" pattern, characterized by grounglass opacities with interspersed interlobular septal thickening.[8]

## Diagnosis

Lipid pneumonia-exogenous

In terms of the evaluation of Lipid pneumonia we find the following:[9]

* Chest X-ray
* CT scan
* Arterial blood gas (pH)
* Bronchoscopy (histological sample)

## Management

There are no specific guidelines for the treatment of the disease. Limited evidence suggest that the corticosteroids and possibly intravenous immunoglobulins may improve condition but in the case of exogenous type the stopping of the offending agent is the step that should be taken first.[9]

## Prognosis

Endogenous lipoid pneumonia and non-specific interstitial pneumonitis has been seen prior to the development of pulmonary alveolar proteinosis in a child.[6]

## Epidemiology

Lipid pneumonia has been known to occur in underwater divers after breathing poorly filtered air supplied by a surface compressor lubricated by mineral oil.[10]

## History

Laughlen first described lipid pneumonia in 1925 with infants that inhaled oil droplets.[10] It is a condition that has been seen as an occupational risk for commercial diving operations but documented cases are rare.[10]

## References

1. ↑ "[Familial cholesterol pneumonia]". Helv Paediatr Acta 27 (4): 371–9. 1972. PMID 4644274.
2. ↑ 2.0 2.1 Moe Bell, Marvin (2015). "Lipoid pneumonia: An unusual and preventable illness in elderly patients". Canadian Family Physician 61 (9): 775–777. PMID 26371101.
3. ↑ "Pulmonary Pathology". http://library.med.utah.edu/WebPath/LUNGHTML/LUNG026.html.
4. ↑ "Recurrent lipoid pneumonia associated with oil pulling". The International Journal of Tuberculosis and Lung Disease 18 (2): 251–2. February 2014. doi:10.5588/ijtld.13.0852. PMID 24429325.
5. ↑ 5.0 5.1 Rl, Hunter; Mr, Olsen; C, Jagannath; Jk, Actor (2006). "Multiple roles of cord factor in the pathogenesis of primary, secondary, and cavitary tuberculosis, including a revised description of the pathology of secondary disease" (in en). Annals of Clinical and Laboratory Science 36 (4): 371–386. ISSN 0091-7370. PMID 17127724. https://pubmed.ncbi.nlm.nih.gov/17127724/.
6. ↑ 6.0 6.1 "Endogenous lipoid pneumonia preceding diagnosis of pulmonary alveolar proteinosis". The Clinical Respiratory Journal 10 (2): 246–249. 2014. doi:10.1111/crj.12197. PMID 25103284.
7. ↑ Zander, Dani S.; Farver, Carol F. (14 December 2016) (in en). Pulmonary Pathology E-Book: A Volume in Foundations in Diagnostic Pathology Series. Elsevier Health Sciences. p. 517. ISBN 978-0-323-46119-1. https://books.google.com/books?id=6Ze_DQAAQBAJ&dq=lipid+pneumonia+gross+pathology&pg=PA517. Retrieved 19 December 2022.
8. ↑ Betancourt, SL; Martinez-Jimenez, S; Rossi, SE; Truong, MT; Carrillo, J; Erasmus, JJ (January 2010). "Lipoid pneumonia: spectrum of clinical and radiologic manifestations.". AJR. American Journal of Roentgenology 194 (1): 103–9. doi:10.2214/AJR.09.3040. PMID 20028911.
9. ↑ 9.0 9.1 Beck, Lauren R.; Landsberg, David (2022). "Lipoid Pneumonia". StatPearls. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK554577/. Retrieved 19 December 2022.
10. ↑ 10.0 10.1 10.2 "Lipoid pneumonitis in a commercial abalone diver". Undersea Biomedical Research 14 (6): 545–52. November 1987. PMID 3686744. http://archive.rubicon-foundation.org/2451. Retrieved 2013-04-02.

## Further reading

* Spickard, Anderson; Hirschmann, JV (28 March 1994). "Exogenous Lipoid Pneumonia". Archives of Internal Medicine 154 (6): 686–92. doi:10.1001/archinte.1994.00420060122013. PMID 8129503.
* Betancourt, SL; Martinez-Jimenez, S; Rossi, SE; Truong, MT; Carrillo, J; Erasmus, JJ (January 2010). "Lipoid pneumonia: spectrum of clinical and radiologic manifestations.". AJR. American Journal of Roentgenology 194 (1): 103–9. doi:10.2214/ajr.09.3040. PMID 20028911.

## External links

Classification|

* ICD-9-CM: 516.8
* OMIM: 215030
* MeSH: D011017

|

* Gross pathology specimen from the University of Utah

* v
* t
* e

Diseases of the respiratory system (J, 460–519)

Upper RT
(including URTIs,
common cold)|

| Head|

sinuses

Sinusitis

nose

Rhinitis

Vasomotor rhinitis
Atrophic rhinitis
Hay fever
Nasal polyp
Rhinorrhea
nasal septum

Nasal septum deviation
Nasal septum perforation
Nasal septal hematoma

tonsil

Tonsillitis
Adenoid hypertrophy
Peritonsillar abscess

|

Neck|

pharynx

Pharyngitis

Strep throat
Laryngopharyngeal reflux (LPR)
Retropharyngeal abscess

larynx

Croup
Laryngomalacia
Laryngeal cyst
Laryngitis
Laryngopharyngeal reflux (LPR)
Laryngospasm

vocal cords

Laryngopharyngeal reflux (LPR)
Vocal fold nodule
Vocal fold paresis
Vocal cord dysfunction

epiglottis

Epiglottitis

trachea

Tracheitis
Laryngotracheal stenosis

Lower RT/lung disease
(including LRTIs)|

| Bronchial/
obstructive|

acute

Acute bronchitis

chronic

COPD

Chronic bronchitis
Acute exacerbation of COPD)
Asthma (Status asthmaticus
Aspirin-induced
Exercise-induced
Bronchiectasis

unspecified

Bronchitis
Bronchiolitis

Bronchiolitis obliterans
Diffuse panbronchiolitis

|

Interstitial/
restrictive
(fibrosis)|

| External agents/
occupational
lung disease|

Pneumoconiosis

Aluminosis
Asbestosis
Baritosis
Bauxite fibrosis
Berylliosis
Caplan's syndrome
Chalicosis
Coalworker's pneumoconiosis
Siderosis
Silicosis
Talcosis
Byssinosis

Hypersensitivity pneumonitis

Bagassosis
Bird fancier's lung
Farmer's lung
Lycoperdonosis

|

Other|

* ARDS
* Combined pulmonary fibrosis and emphysema
* Pulmonary edema
* Löffler's syndrome/Eosinophilic pneumonia
* Respiratory hypersensitivity
* Allergic bronchopulmonary aspergillosis
* Hamman-Rich syndrome
* Idiopathic pulmonary fibrosis
* Sarcoidosis
* Vaping-associated pulmonary injury

Obstructive or
restrictive|

| Pneumonia/
pneumonitis|

| By pathogen|

* Viral
* Bacterial
* Pneumococcal
* Klebsiella
* Atypical bacterial
* Mycoplasma
* Legionnaires' disease
* Chlamydiae
* Fungal
* Pneumocystis
* Parasitic
* noninfectious
* Chemical/Mendelson's syndrome
* Aspiration/Lipid

|

By vector/route|

* Community-acquired
* Healthcare-associated
* Hospital-acquired

By distribution|

* Broncho-
* Lobar

IIP|

* UIP
* DIP
* BOOP-COP
* NSIP
* RB

Other|

* Atelectasis
* circulatory
* Pulmonary hypertension
* Pulmonary embolism
* Lung abscess

Pleural cavity/
mediastinum|

| Pleural disease|

* Pleuritis/pleurisy

* [[Medicine:PneumoPneumothorax]]/Hemopneumothorax

Pleural effusion

Hemothorax
Hydrothorax
Chylothorax
Empyema/pyothorax
Malignant

Fibrothorax

|

Mediastinal disease|

* Mediastinitis
* Mediastinal emphysema

Other/general|

* Respiratory failure
* Influenza
* SARS
* Coronavirus disease 2019
* Idiopathic pulmonary haemosiderosis
* Pulmonary alveolar proteinosis

* v
* t
* e

Pneumonia

Infectious pneumonias|

* Bacterial pneumonia
* Viral pneumonia
* Fungal pneumonia
* Parasitic pneumonia
* Atypical pneumonia
* Community-acquired pneumonia
* Healthcare-associated pneumonia
* Hospital-acquired pneumonia
* Ventilator-associated pneumonia
* Severe acute respiratory syndrome

Pneumonias caused by
infectious or noninfectious agents|

* Aspiration pneumonia
* Lipid pneumonia
* Eosinophilic pneumonia
* Bronchiolitis obliterans organizing pneumonia

Noninfectious pneumonia|

* Chemical pneumonitis
* Idiopathic pneumonia syndrome

0.00

(0 votes)

|

Retrieved from "https://handwiki.org/wiki/index.php?title=Medicine:Lipid_pneumonia&oldid=3271631"
*[v]: View this template
*[t]: Discuss this template
*[e]: Edit this template